2023-05-02 05:14:00 ET
If you're a long-term Dexcom (NASDAQ: DXCM) shareholder, congratulations. A $1,000 bet placed on this developer of blood sugar monitoring devices a decade ago is worth nearly $30,000 today.
Sadly, past performance doesn't guarantee future results. If anything, Dexcom's success to date makes continued growth at its previous pace extra challenging.
Shares of Dexcom recently dipped a couple of percentage points after the company shared results from the first three months of 2023. Is the stock's recent slip a sign that investors should avoid this former highflier or is it an opportunity to buy a great stock at a bargain price ?
For further details see:
Is Dexcom a Good Stock to Buy Now?